key: cord-0263164-rnilge14
authors: Sartor, I. T. S.; David, C. N.; Telo, G. H.; Zavaglia, G. O.; Fernandes, I. R.; Kern, L. B.; Polese-Bonatto, M.; Azevedo, T. R.; Santos, A. P.; Almeida, W. A. F.; Porto, V. B. G.; Varela, F. H.; Scotta, M. C.; Rosa, R. G.; Stein, R. T.
title: Association between obesity and hospitalization in mild COVID-19 young adult outpatients in Brazil: a prospective cohort study
date: 2021-08-05
journal: nan
DOI: 10.1101/2021.08.04.21261538
sha: ef7b68955c449232460b70ff9f88bad17aa1c1e5
doc_id: 263164
cord_uid: rnilge14

Background/Objectives The aim of this study was to evaluate the association between obesity and hospitalization in mild COVID-19 adult outpatients in Brazil. Subjects/Methods Adults with signs and symptoms suggestive of acute SARS-CoV-2 infection who sought two hospitals (one public and one private) emergency department were prospectively enrolled. Patients with confirmed COVID-19 at inclusion were followed by phone calls at day (D) D7, D14 and D28. Multivariable logistic regression models were employed to explore the association between obesity and other potential predictors for hospitalization. Results A total of 1,050 participants were screened, 310 were diagnosed with COVID-19 by RT-PCR. Median age was 37.4 (IQR 29.8-45.0) years, and 186 (60.0%) were female. Duration of symptoms was 3.0 (IQR 2.0-5.0) days, and 10.0 (IQR 8.0-12.0) was the median number of symptoms at inclusion. A total of 98 (31.6%) were obese, and 243 (78.4%) had no previous medical conditions. Twenty three participants (23/310, 7.4%) required hospitalization during the period. After adjusting, obesity (BMI[≥]30.0 kg/m2) (OR=2.69, 95%CI 1.63-4.83, P<0.001) and older age (OR=1.05, 95%CI 1.01-1.09, P<0.001), were significantly associated with higher risks of hospitalization. Conclusions Obesity, followed by aging, was the main factor associated with hospital admission for COVID-19 in a young population in a low-middle income country. Our findings highlighted the need for actions to promote additional protection for obese population, such as vaccination, and to encourage lifestyle changes.

4 between obesity and hospitalization in mild COVID-19 adult outpatients in Brazil. We also 76 aimed to describe the clinical characteristics of COVID-19 outpatients and identify other 77 predictors of hospitalization. 78 when it was not possible to make any contact in different day periods (including failure in 10 103 call attempts or time exceeded considering 3-day window) within the 28-day follow-up. 104

During the follow up interviews, participants were asked about the need of hospital 105 admission, use of supplemental oxygen, admission at intensive care units (ICU), and use of 106 invasive mechanical ventilation. All data were collected by trained researchers and using 107 standardized questionnaires developed for the study in the Research Electronic Data 108

Capture software (REDCap) 7,8 . 109

The outcome of interest was unplanned hospital admission in the period of 28 days. In order 110 to predict the outcome, demographic and clinical characteristics as age at time of enrollment 111 (years), sex, days of onset of symptoms, racial or ethnic group, active or second hand 112 smoke at home, hospital at inclusion, number of symptoms and number of medical 113 conditions were considered. In order to evaluate obesity as a predictor for the outcome of 114 interest, we used BMI and participants were classified as non-obese (<30.0 kg/m 2 ), and 115 obesity (≥30.0 kg/m 2 ). 116

Data normality assumptions were verified using the Shapiro-Wilk test for continuous 118 variables, median values and interquartile ranges (IQR) were calculated, and two-tailed 119

Mann-Whitney-Wilcoxon test was used. Pearson's Chi-square or Fisher's exact tests were 120 used to evaluate proportions. Uni and multivariable logistic regression analyses were 121 performed to assess the predictors of hospitalization considering the follow up period of 28 122 days after having a COVID-19 health care visit (study baseline). The association between 123 obesity and hospitalization was assessed using multiple logistic regression models with 124 adjustment for relevant covariates (hospital at inclusion; years of education; number of 125 medical conditions (none, one, two or more); days of onset of symptoms to inclusion; 126 number of symptoms (≤8, 9-10, 11-12, ≥ 13); and cardiovascular diseases, which includes: 127 ischemic heart disease, heart failure and hypertension). We performed additional models 128 including covariates considered risk factors to hospitalization in order to assess consistency 129 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 5, 2021. ;

The world is still struggling to fight the COVID-19 pandemic. According to the World Health 186 Organization (WHO), the mortality rate from COVID-19 is 0.5-1.0% 12 , while the 187 hospitalization rate for the disease is 5.0-15.0%. Based on currently available information, 188 the Centers for Disease Control and Prevention has identified severe obesity as an 189 important risk factor for worse prognosis and higher mortality in patients with 190 while any degree of obesity has been associated with COVID-19 poor prognosis. In our consortium: Building an international community of software platform partners. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 5, 2021. ; https://doi.org/10.1101/2021.08.04.21261538 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 5, 2021. ; Table 1 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 5, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 5, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 5, 2021. 

Social Responsibility -PROADI-SUS, Hospital Moinhos de Vento